Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1395

1.

Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice.

Wang W, Tsuchiya K, Kurosaki M, Yasui Y, Inada K, Kirino S, Yamashita K, Sekiguchi S, Hayakawa Y, Osawa L, Okada M, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Izumi N.

Cancers (Basel). 2019 Oct 9;11(10). pii: E1517. doi: 10.3390/cancers11101517.

2.

Improved regional myocardial blood flow and flow reserve after coronary revascularization as assessed by serial 15O-water positron emission tomography/computed tomography.

Aikawa T, Naya M, Koyanagawa K, Manabe O, Obara M, Magota K, Oyama-Manabe N, Tamaki N, Anzai T.

Eur Heart J Cardiovasc Imaging. 2019 Sep 23. pii: jez220. doi: 10.1093/ehjci/jez220. [Epub ahead of print]

PMID:
31544927
3.

Multiple Absolute Stereocontrol in Cascade Lactone Formation via Dynamic Kinetic Resolution Driven by the Asymmetric Transfer Hydrogenation of Keto Acids with Oxo-Tethered Ruthenium Catalysts.

Touge T, Sakaguchi K, Tamaki N, Nara H, Yokozawa T, Matsumura K, Kayaki Y.

J Am Chem Soc. 2019 Oct 16;141(41):16354-16361. doi: 10.1021/jacs.9b07297. Epub 2019 Sep 24.

PMID:
31502833
4.

Early effects of transcatheter aortic valve replacement on cardiac sympathetic nervous function assessed by 123I-metaiodobenzylguanidine scintigraphy in patients with severe aortic valve stenosis.

Kadoya Y, Zen K, Tamaki N, Ito N, Kuwabara K, Yamano M, Yamano T, Nakamura T, Matsushima S, Oka K, Numata S, Yaku H, Matoba S.

Eur J Nucl Med Mol Imaging. 2019 Sep 9. doi: 10.1007/s00259-019-04523-0. [Epub ahead of print]

PMID:
31502014
5.

Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma.

Takada H, Kurosaki M, Tsuchiya K, Komiyama Y, Itakura J, Takahashi Y, Nakanishi H, Yasui Y, Tamaki N, Maeyashiki C, Kaneko S, Takaura K, Higuchi M, Okada M, Wang W, Osawa L, Sekiguchi S, Hayakawa Y, Yamashita K, Enomoto N, Izumi N.

Cancers (Basel). 2019 Aug 27;11(9). pii: E1256. doi: 10.3390/cancers11091256.

6.

New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.

Koizumi Y, Hirooka M, Tamaki N, Yada N, Nakashima O, Izumi N, Kudo M, Hiasa Y.

PLoS One. 2019 Aug 27;14(8):e0221548. doi: 10.1371/journal.pone.0221548. eCollection 2019.

7.

Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib.

Kaneko S, Tsuchiya K, Kurosaki M, Kirino S, Inada K, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Watakabe K, Okada M, Wang W, Shimizu T, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Takeguchi T, Takeguchi Y, Nakanishi H, Itakura J, Takahashi Y, Himeno Y, Izumi N.

Hepatol Res. 2019 Jul 26. doi: 10.1111/hepr.13416. [Epub ahead of print]

PMID:
31349377
8.

The Roles of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment.

Hirata K, Yamaguchi S, Shiga T, Kuge Y, Tamaki N.

J Clin Med. 2019 Jul 24;8(8). pii: E1088. doi: 10.3390/jcm8081088. Review.

9.

Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease.

Tamaki N, Higuchi M, Kurosaki M, Kirino S, Osawa L, Watakabe K, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N.

Sci Rep. 2019 Jul 12;9(1):10109. doi: 10.1038/s41598-019-46172-1.

10.

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO.

Watanabe S, Shiga T, Hirata K, Magota K, Okamoto S, Toyonaga T, Higashikawa K, Yasui H, Kobayashi J, Nishijima KI, Iseki K, Matsumoto H, Kuge Y, Tamaki N.

EJNMMI Res. 2019 Jul 5;9(1):60. doi: 10.1186/s13550-019-0525-6.

11.

A survey of Lasioderma serricorne (Fabricius) in Japanese Dental Clinics.

Watanabe A, Takaku S, Yokota K, Hayashi S, Tamaki N, Kokeguchi S.

Biocontrol Sci. 2019;24(2):117-121. doi: 10.4265/bio.24.117.

12.

Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models.

Zhao S, Yu W, Ukon N, Tan C, Nishijima KI, Shimizu Y, Higashikawa K, Shiga T, Yamashita H, Tamaki N, Kuge Y.

EJNMMI Res. 2019 Jun 3;9(1):51. doi: 10.1186/s13550-019-0521-x.

13.

Impact of renal dysfunction on the choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina.

Kato T, Uemura Y, Naya M, Momose M, Matsumoto N, Suzuki E, Hida S, Nakajima T, Yamauchi T, Tamaki N.

Sci Rep. 2019 May 27;9(1):7882. doi: 10.1038/s41598-019-44371-4.

14.

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate.

Kaneko S, Kurosaki M, Tamaki N, Itakura J, Hayashi T, Kirino S, Osawa L, Watakabe K, Okada M, Wang W, Shimizu T, Higuchi M, Takaura K, Yasui Y, Tsuchiya K, Nakanishi H, Takahashi Y, Watanabe M, Izumi N.

J Gastroenterol Hepatol. 2019 Apr 24. doi: 10.1111/jgh.14686. [Epub ahead of print]

PMID:
31017689
15.

Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals.

Tamaki N, Higuchi M, Kurosaki M, Kirino S, Osawa L, Watakabe K, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N.

J Viral Hepat. 2019 Jul;26(7):893-899. doi: 10.1111/jvh.13103. Epub 2019 May 3.

PMID:
30974045
16.

Comparative evaluation of [18F]DiFA and its analogs as novel hypoxia positron emission tomography and [18F]FMISO as the standard.

Nakata N, Kiriu M, Okumura Y, Zhao S, Nishijima KI, Shiga T, Tamaki N, Kuge Y, Matsumoto H.

Nucl Med Biol. 2019 Mar;70:39-45. doi: 10.1016/j.nucmedbio.2019.01.008. Epub 2019 Feb 8.

PMID:
30836255
17.

Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.

Kroenke M, Hirata K, Gafita A, Watanabe S, Okamoto S, Magota K, Shiga T, Kuge Y, Tamaki N.

PLoS One. 2019 Feb 28;14(2):e0213111. doi: 10.1371/journal.pone.0213111. eCollection 2019.

18.

Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis.

Koyanagawa K, Naya M, Aikawa T, Manabe O, Kuzume M, Ohira H, Tsujino I, Tamaki N, Anzai T.

J Nucl Cardiol. 2019 Feb 27. doi: 10.1007/s12350-019-01660-9. [Epub ahead of print]

PMID:
30815835
19.

Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.

Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Shimizu T, Watakabe K, Enomoto N, Izumi N.

PLoS One. 2019 Feb 15;14(2):e0211122. doi: 10.1371/journal.pone.0211122. eCollection 2019.

20.

Reply.

Tamaki N, Kurosaki M, Izumi N.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1419-1420. doi: 10.1016/j.cgh.2019.01.038. Epub 2019 Jan 30. No abstract available.

PMID:
30710699
21.

New trials for assessment of left atrial dysfunction by FDG-PET.

Naya M, Manabe O, Tamaki N.

J Nucl Cardiol. 2019 Feb 1. doi: 10.1007/s12350-018-01495-w. [Epub ahead of print] No abstract available.

PMID:
30710316
22.

Accumulation of hypoxia imaging probe "18F-FMISO" in macrophages depends on macrophage polarization in addition to hypoxic state.

Shimizu Y, Motomura A, Takakura H, Tamaki N, Kuge Y, Ogawa M.

Ann Nucl Med. 2019 May;33(5):362-367. doi: 10.1007/s12149-019-01332-1. Epub 2019 Jan 29.

PMID:
30694443
23.

18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis.

Omote K, Naya M, Koyanagawa K, Aikawa T, Manabe O, Nagai T, Kamiya K, Kato Y, Komoriyama H, Kuzume M, Tamaki N, Anzai T.

J Nucl Cardiol. 2019 Jan 4. doi: 10.1007/s12350-018-01541-7. [Epub ahead of print]

PMID:
30610523
24.

Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance Elastography.

Higuchi M, Tamaki N, Kurosaki M, Watakabe K, Osawa L, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Izumi N.

Clin Gastroenterol Hepatol. 2018 Nov 28. pii: S1542-3565(18)31323-5. doi: 10.1016/j.cgh.2018.11.046. [Epub ahead of print]

PMID:
30502507
25.

Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection.

Yasui Y, Abe T, Kurosaki M, Matsunaga K, Higuchi M, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Takaura K, Masugi Y, Nakanishi H, Tsuchiya K, Takahashi Y, Itakura J, Sakurai U, Hashiguchi A, Sakamoto M, Izumi N.

Hepatol Res. 2019 Jan;49(1):33-41. doi: 10.1111/hepr.13286. Epub 2018 Dec 26.

PMID:
30419152
26.

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines.

Namatame N, Tamaki N, Yoshizawa Y, Okamura M, Nishimura Y, Yamazaki K, Tanaka M, Nakamura T, Semba K, Yamori T, Yaguchi SI, Dan S.

Oncotarget. 2018 Oct 12;9(80):35141-35161. doi: 10.18632/oncotarget.26216. eCollection 2018 Oct 12.

27.

Use of 18F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis.

Manabe O, Ohira H, Hirata K, Hayashi S, Naya M, Tsujino I, Aikawa T, Koyanagawa K, Oyama-Manabe N, Tomiyama Y, Magota K, Yoshinaga K, Tamaki N.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1240-1247. doi: 10.1007/s00259-018-4195-9. Epub 2018 Oct 16.

PMID:
30327855
28.

Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.

Kitao T, Shiga T, Hirata K, Sekizawa M, Takei T, Yamashiro K, Tamaki N.

Ann Nucl Med. 2019 Jan;33(1):22-31. doi: 10.1007/s12149-018-1298-0. Epub 2018 Sep 8.

PMID:
30196378
29.

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Takeuchi S, Shiga T, Hirata K, Taguchi J, Magota K, Ariga S, Gouda T, Ohhara Y, Homma R, Shimizu Y, Kinoshita I, Tsuji Y, Homma A, Iijima H, Tamaki N, Dosaka-Akita H.

BMJ Open. 2018 Aug 30;8(8):e021001. doi: 10.1136/bmjopen-2017-021001.

30.

Assessment of Coronary Flow Velocity Reserve in the Left Main Trunk Using Phase-contrast MR Imaging at 3T: Comparison with 15O-labeled Water Positron Emission Tomography.

Kikuchi Y, Naya M, Oyama-Manabe N, Manabe O, Sugimori H, Kudo K, Kato F, Aikawa T, Tsutsui H, Tamaki N, Shirato H.

Magn Reson Med Sci. 2019 Apr 10;18(2):134-141. doi: 10.2463/mrms.mp.2018-0003. Epub 2018 Jul 26.

31.

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus.

Yasui Y, Kurosaki M, Komiyama Y, Takada H, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Kubota Y, Higuchi M, Takaura K, Tsuchiya K, Nakanishi H, Takahashi Y, Itakura J, Enomoto N, Izumi N.

Hepatol Res. 2018 Dec;48(13):1131-1139. doi: 10.1111/hepr.13233. Epub 2018 Aug 23.

PMID:
30030872
32.

Value of simultaneous assessment of cardiac functions by PET/MRI.

Tamaki N, Matsushima S, Nishimura M.

J Nucl Cardiol. 2018 Jul 20. doi: 10.1007/s12350-018-1341-5. [Epub ahead of print] No abstract available.

PMID:
30030784
33.

Effects of coronary revascularization on global coronary flow reserve in stable coronary artery disease.

Aikawa T, Naya M, Obara M, Manabe O, Magota K, Koyanagawa K, Asakawa N, Ito YM, Shiga T, Katoh C, Anzai T, Tsutsui H, Murthy VL, Tamaki N.

Cardiovasc Res. 2019 Jan 1;115(1):119-129. doi: 10.1093/cvr/cvy169.

34.

Diagnostic value of quantitative coronary flow reserve and myocardial blood flow estimated by dynamic 320 MDCT scanning in patients with obstructive coronary artery disease.

Obara M, Naya M, Oyama-Manabe N, Aikawa T, Tomiyama Y, Sasaki T, Kikuchi Y, Manabe O, Katoh C, Tamaki N, Tsutsui H.

Medicine (Baltimore). 2018 Jul;97(27):e11354. doi: 10.1097/MD.0000000000011354.

35.

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Enomoto N, Izumi N.

PLoS One. 2018 Jun 18;13(6):e0198812. doi: 10.1371/journal.pone.0198812. eCollection 2018.

36.

Long-term events after physician-referred initial tests by myocardial perfusion imaging or computed tomography coronary angiography in patients with suspected coronary artery disease.

Naya M, Uemura Y, Matsumoto N, Momose M, Kato T, Hida S, Yamauchi T, Nakajima T, Suzuki E, Tamaki N; J-COMPASS Extended Follow-Up Study Group.

Coron Artery Dis. 2018 Nov;29(7):539-546. doi: 10.1097/MCA.0000000000000645.

PMID:
29877870
37.

The role of multimodality imaging in takotsubo cardiomyopathy.

Manabe O, Naya M, Oyama-Manabe N, Koyanagawa K, Tamaki N.

J Nucl Cardiol. 2019 Oct;26(5):1602-1616. doi: 10.1007/s12350-018-1312-x. Epub 2018 Jun 1.

PMID:
29858766
38.

A Novel PET Probe "[18F]DiFA" Accumulates in Hypoxic Region via Glutathione Conjugation Following Reductive Metabolism.

Shimizu Y, Zhao S, Yasui H, Nishijima KI, Matsumoto H, Shiga T, Tamaki N, Ogawa M, Kuge Y.

Mol Imaging Biol. 2019 Feb;21(1):122-129. doi: 10.1007/s11307-018-1214-y.

PMID:
29845425
39.

Preventive effects of mouthguard use while sleeping on recurrent aphthous stomatitis: Preliminary interventional study.

Tada H, Fujiwara N, Tsunematsu T, Tada Y, Arakaki R, Tamaki N, Ishimaru N, Kudo Y.

Clin Exp Dent Res. 2017 Oct 11;3(5):198-203. doi: 10.1002/cre2.88. eCollection 2017 Oct.

40.

[18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia.

Tan C, Zhao S, Higashikawa K, Wang Z, Kawabori M, Abumiya T, Nakayama N, Kazumata K, Ukon N, Yasui H, Tamaki N, Kuge Y, Shichinohe H, Houkin K.

EJNMMI Res. 2018 May 2;8(1):35. doi: 10.1186/s13550-018-0392-6.

41.

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.

Tamaki N, Koizumi Y, Hirooka M, Yada N, Takada H, Nakashima O, Kudo M, Hiasa Y, Izumi N.

Hepatol Res. 2018 Sep;48(10):821-828. doi: 10.1111/hepr.13179. Epub 2018 May 18.

PMID:
29679473
42.

Use of ATP bioluminescence to survey the spread of aerosol and splatter during dental treatments.

Watanabe A, Tamaki N, Yokota K, Matsuyama M, Kokeguchi S.

J Hosp Infect. 2018 Jul;99(3):303-305. doi: 10.1016/j.jhin.2018.03.002. Epub 2018 Mar 16.

PMID:
29551649
43.

Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on 18F-FDG PET/CT.

Furuya S, Manabe O, Nanbu T, Yamashita N, Shinnno Y, Kasai K, Kroenke M, Tamaki N.

Intern Med. 2018 Apr 15;57(8):1131-1134. doi: 10.2169/internalmedicine.9523-17. Epub 2017 Dec 27.

44.

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.

Yasui Y, Tsuchiya K, Kurosaki M, Takeguchi T, Takeguchi Y, Okada M, Wang W, Kubota Y, Goto T, Komiyama Y, Higuchi M, Takaura K, Hayashi T, Takada H, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Himeno Y, Izumi N.

Hepatol Res. 2018 May;48(6):442-450. doi: 10.1111/hepr.13048. Epub 2018 Feb 9.

PMID:
29278654
45.

Quantification of myocardial blood flow with 11C-hydroxyephedrine dynamic PET: comparison with 15O-H2O PET.

Hiroshima Y, Manabe O, Naya M, Tomiyama Y, Magota K, Obara M, Aikawa T, Oyama-Manabe N, Yoshinaga K, Hirata K, Kroenke M, Tamaki N, Katoh C.

J Nucl Cardiol. 2017 Dec 21. doi: 10.1007/s12350-017-1140-4. [Epub ahead of print]

PMID:
29270771
46.

Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.

Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A, Oyama-Manabe N, Hirata K, Watanabe S, Shiga T, Katoh C, Tamaki N.

J Nucl Cardiol. 2019 Jun;26(3):909-918. doi: 10.1007/s12350-017-1122-6. Epub 2017 Dec 14.

PMID:
29243072
47.

2017 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine.

Tamaki N.

J Nucl Med. 2017 Dec;58(12):9N-14N. No abstract available.

48.

Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination of 11C-HED PET and 123I-MIBG SPECT.

Tokuda Y, Sakakibara M, Yoshinaga K, Yamada S, Kamiya K, Asakawa N, Yoshitani T, Noguchi K, Manabe O, Tamaki N, Tsutsui H.

J Nucl Cardiol. 2019 Aug;26(4):1079-1089. doi: 10.1007/s12350-017-1132-4. Epub 2017 Nov 27.

49.

Correction to: The role of nuclear medicine in assessments of cardiac dyssynchrony.

Naya M, Manabe O, Koyanagawa K, Tamaki N.

J Nucl Cardiol. 2018 Dec;25(6):1988-1989. doi: 10.1007/s12350-017-1113-7.

PMID:
29143244
50.

Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.

Sakamoto K, Oyama-Manabe N, Manabe O, Aikawa T, Kikuchi Y, Sasai-Masuko H, Naya M, Kudo K, Kato F, Tamaki N, Shirato H.

Jpn J Radiol. 2018 Feb;36(2):103-112. doi: 10.1007/s11604-017-0700-5. Epub 2017 Nov 9.

PMID:
29119456

Supplemental Content

Loading ...
Support Center